Showing 9 of 9 recruiting trials for “Adult T-cell leukemia/lymphoma”
Azacitidine and Abatacept in Relapsed or Refractory T-Cell Lymphoma
Venetoclax Combined With Azacitidine, Chidamide, Vindesine, and Dexamethasone in Newly Diagnosed ETP-ALL Like Patients
A Phase I Dose Finding Study of MB-CART2219.1
A Study of Mogamulizumab to Prevent Adult T-cell Leukemia/Lymphoma in People With HTLV-1
👨⚕️ Steven Horwitz, MD, Memorial Sloan Kettering Cancer Center📍 7 sites📅 Started Nov 2024View details ↗
Sequential CAR-T Cells Therapy for CD5/CD7 Positive T-cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma Using CD5/CD7-Specific CAR-T Cells
A Phase I/II Study of OJP-001 in Patients With Adult T-cell Leukemia/Lymphoma
RecruitingNCT06131801 ↗
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
👨⚕️ Lauren Pommert, MD, Children's Hospital Medical Center, Cincinnati📍 5 sites📅 Started Nov 2023View details ↗
RecruitingNCT05978141 ↗
A Registry for People With T-cell Lymphoma
👨⚕️ Steven Horwitz, MD, Memorial Sloan Kettering Cancer Center📍 26 sites📅 Started Jul 2023View details ↗
Third-Party Natural Killer Cells and Mogamulizumab for the Treatment of Relapsed or Refractory Cutaneous T-cell Lymphomas or Adult T-Cell Leukemia/Lymphoma
👨⚕️ John C Reneau, MD, PhD, Ohio State University Comprehensive Cancer Center📍 1 site📅 Started May 2022View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →